Actively Recruiting
Pforzheim Tricuspid Valve Registry - Outcomes of Percutaneous Tricuspid Valve Repair
Led by Helios Klinikum Pforzheim · Updated on 2023-09-22
200
Participants Needed
1
Research Sites
313 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The Pforzheim Tricuspid Valve Registry study is designed to confirm the safety and performance of the TriClip™ device in a contemporary real-world setting in critically ill patients. The observational trial is a prospective, single arm, open-label, single-center, post market registry.
CONDITIONS
Official Title
Pforzheim Tricuspid Valve Registry - Outcomes of Percutaneous Tricuspid Valve Repair
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Severe tricuspid regurgitation with symptoms despite medical therapy
- Eligible to receive the TriClip device
- Must provide written informed consent before the procedure
You will not qualify if you...
- Participation in another clinical study that could affect follow-up or results
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Helios Klinikum Pforzheim
Pforzheim, Germany, 75175
Actively Recruiting
Research Team
I
Ilka Ott, MD, PhD
CONTACT
A
Alexandru Patrascu, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here